Get the Stockscreener App
2.93
2.09%
0.06
Cerus Corp stock is traded at $2.93, with a volume of 2.51M.
It is up +2.09% in the last 24 hours and up +10.98% over the past month.
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety, and generates revenue from the same.
See More
Previous Close:
$2.87
Open:
$2.87
24h Volume:
2.51M
Relative Volume:
0.92
Market Cap:
$587.08M
Revenue:
$216.56M
Net Income/Loss:
$-9.57M
P/E Ratio:
-58.95
EPS:
-0.0497
Net Cash Flow:
$-1.22M
1W Performance:
-6.39%
1M Performance:
+10.98%
6M Performance:
+17.67%
1Y Performance:
+115.44%
1-Day Range:
$2.8098
$2.94
1-Week Range:
$2.8098
$3.23
52-Week Range:
$1.15
$3.4698
Cerus Corp Stock (CERS) Company Profile
Name
Cerus Corp
Sector
Industry
Phone
(925) 288-6000
Address
1220 CONCORD AVENUE, CONCORD, CA
Compare CERS vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CERS
Cerus Corp
|
2.93 | 587.08M | 216.56M | -9.57M | -1.22M | -0.0497 |
ABT
Abbott Laboratories
|
103.06 | 179.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
330.25 | 126.60B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.21 | 106.51B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
44.25 | 65.77B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.63 | 47.58B | 6.30B | 1.07B | 1.09B | 1.8406 |
Cerus Corp Stock (CERS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-12-24 | Initiated | Craig Hallum | Buy |
| Jan-20-23 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-17-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Oct-08-20 | Resumed | BTIG Research | Buy |
| Jun-16-20 | Resumed | Cantor Fitzgerald | Overweight |
| Feb-26-20 | Initiated | BTIG Research | Buy |
| Nov-13-19 | Upgrade | BTIG Research | Neutral → Buy |
| Aug-28-19 | Initiated | Stifel | Buy |
| Aug-23-19 | Resumed | Stephens | Overweight |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Overweight |
| Dec-08-17 | Resumed | BTIG Research | Neutral |
| Jul-07-16 | Resumed | Cantor Fitzgerald | Buy |
| Dec-17-15 | Downgrade | Wedbush | Outperform → Neutral |
| May-02-14 | Reiterated | MLV & Co | Buy |
| Apr-24-13 | Reiterated | Cantor Fitzgerald | Buy |
| Mar-15-13 | Reiterated | MLV & Co | Buy |
| Apr-17-12 | Initiated | Cantor Fitzgerald | Buy |
| Feb-29-12 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-10-11 | Reiterated | MLV & Co | Buy |
| Jun-03-11 | Initiated | Wedbush | Outperform |
| Mar-04-11 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-09-10 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Aug-26-09 | Upgrade | Avondale | Mkt Perform → Mkt Outperform |
View All
Cerus Corp Stock (CERS) Latest News
CERS|Cerus Corp|Price:2.879|Chg%:-0.141 - TradingKey
Cerus (CERS) to Announce Quarterly Earnings on Thursday - MarketBeat
AlTi Global Leads Our Selection Of 3 Promising Penny Stocks - simplywall.st
Cerus Corp (CERS) CEO trades 16666 shares under 10b5-1 plan - Stock Titan
Cerus Corporation (CERS) Edges Higher as Stock Holds Above Key SupportDiagonal Spread Trade - dars.gov.et
Cerus Corp (CERS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cerus Corporation (NASDAQ:CERS) Short Interest Down 35.3% in June - MarketBeat
CERS: Cerus Corp. Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Press Release: Cerus Corporation to Release Second Quarter 2026 Financial Results on July 30, 2026 - Moomoo
Cerus Corporation to release Q2 2026 results on July 30 - scanx.trade
CERS shareholder (NASDAQ: CERS) details planned stock sales in 2026 - Stock Titan
Cerus to Discuss Results and Outlook in July 30 Webcast - Stock Titan
Cerus Corporation Announces Executive Chairman Transition and Employment Agreement Amendment – SEC 8-K Filing July 2026 - Minichart
Cerus Corporation (CERS) defines pay and term for William Greenman as Executive Chairman - Stock Titan
Cerus Corp faces a complex landscape as blood safety technology evolves - Ad-hoc-news.de
ETFs Investing in Cerus Corporation Stocks - TradingView
Cerus Corp updates focus on blood safety. Business model supports long-term growth - AD HOC NEWS
Cerus Corp looks to blood safety technology as investors weigh long-term growth - ad-hoc-news.de
Cerus Company Profile & Introduction - Moomoo
CERSCerus Corp Latest SEC Filings - Finviz
CERS Should I Buy - Intellectia AI
Cerus CEO William Greenman sells $299,937 in common stock - Investing.com UK
Cerus Corp chief legal officer Chrystal Jensen sells $71,597 in stock - Investing.com Nigeria
Cerus CFO Kevin Green sells $99,105 in CERS shares - Investing.com
Cerus COO Vivek Jayaraman disposes of $124,658 in stock for taxes - Investing.com
Cerus CFO Kevin Green sells $99,105 in CERS shares By Investing.com - Investing.com Nigeria
Form 4 Cerus Corporation For: 2 July By Investing.com - Investing.com Canada
Cerus CEO William Greenman sells $299,937 in common stock By Investing.com - Investing.com Canada
Cerus (CERS) CFO logs tax-related share sale and new stock grant - Stock Titan
Cerus (CERS) COO granted RSUs, performance rights and sells shares - Stock Titan
Cerus (NASDAQ: CERS) CLO reports Rule 10b5-1 tax sale and 55,000-share grant - Stock Titan
CERUS (CERS) CEO Greenman logs tax-related share sale and 192,500-share grant - Stock Titan
Cerus Corporation (CERS) Surges 9.66%: Testing Resistance Near $3.04Large Cap Trends - dars.gov.et
Cerus Corp (CERS) Institutional Confidence - TradingKey
Cerus StockFriday sector check and transfusion focus - AD HOC NEWS
CERUS CORP (CERS) Stock Chart - ChartMill
Cerus Corp (CERS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cerus Corp (CERS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Cerus Corp (CERS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cerus Corp (CERS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Cerus Corp (CERS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Cerus Corp (CERS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Cerus Corp (CERS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cerus takes INTERCEPT blood system data to global transfusion congress - Stock Titan
Cerus Corporation (CERS) Closes New Debt Facility of Up to $110M - Insider Monkey
5 Best Genomics Stocks to Buy According to Analysts - Insider Monkey
Cerus Corporation (NASDAQ:CERS) Sees Significant Decrease in Short Interest - MarketBeat
Cerus Corp director Eric Bjerkholt sells $53,180 in stock By Investing.com - Investing.com Australia
Director Eric Bjerkholt Sells 20,454 Shares of Cerus Corp (CERS) - GuruFocus
Cerus Corp director Eric Bjerkholt sells $53,180 in stock - Investing.com UK
Cerus Corp (CERS) director sells 20,454 common shares in open-market trade - Stock Titan
Cerus Corp Stock (CERS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.90%
2.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):